Know What’s New With RSV Vaccines for Older Adults

August 2024

You’ll see new recommendations for respiratory syncytial virus (RSV) immunization in older adults.

Abrysvo and Arexvy are approved for adults ages 60 and older, but Health Canada is now advising to prioritize these vaccines for patients at highest risk of severe illness from RSV.

Age 75 and older. Recommend RSV vaccination for ALL patients 75 and older...particularly those with conditions that increase the risk of severe RSV, or if they are residents of long-term care facilities.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Insulin Be Up on the Buzz Around the First Once-Weekly Insulin
Immunizations Know What’s New With RSV Vaccines for Older Adults
Cardiology Optimize Management of Peripheral Artery Disease
Ulcerative Colitis Provide Guidance on Oral Etrasimod for Ulcerative Colitis
Communication Raise the Communication Bar With “SBAR”
STIs Be Ready for Conversations About “Doxy PEP”
Anticoagulants Help Manage and Prevent Cancer-Associated VTE
NatMed Spotlight Be Prepared With Guidance About Ashwagandha

Know What’s New With RSV Vaccines for Older Adults

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents